Cat.#: ACPP-1846
| Despition | FGF 9 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% by RP-HPLC and SDS-PAGE. |
| Form | Sterile Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1440 | Human SIRPA Protein (AC1440) | 5 µg | inquiry |
| ACPP-1544 | Human GAPDH Protein (AC1544) | 5 µg | inquiry |
| ACPP-1668 | Human BDNF Protein, His (AC1668) | 5 µg | inquiry |
| ACPP-1639 | Human NGFR Protein (AC1639) | 2 µg | inquiry |
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1109 | Recombinant Human Somatostatin Receptor 2 Protein (Fc Tag) (AC1109) | 50 µg | inquiry |
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg | inquiry |
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.